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The novel coronavirus also known as severe acute respiratory syndrome  
coronavirus 2 (SARS-CoV-2) whose origin is still having uncertainties related to 
the existence of an intermediate host, has created the currently ongoing pandemic 
of coronavirus disease 2019. (COVID-19) The binding assays of SARS-CoV-2 
spike protein receptor binding domain disclosed enhanced affinity with human 
angiotensin II-converting enzyme receptor (hACE2) comparing to the bat ACE2 
receptors. ACE2, is an essential component of the regulatory mechanism of the 
renin-angiotensin-aldosterone system, (RAAS) and this pathway is considered to 
interact with the pathophysiology of COVID-19. In this chapter, we will discuss the 
key role of RAAS in the pathogenesis of SARS-CoV-2.
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1. Introduction
1.1  The pathogenic interaction of SARS-CoV-2 and renin: angiotensin: 
aldosterone system
Coronaviruses (CoVs) belong to the family of Coronaviridae which is further 
divided into four genera as Alphacoronavirus, (α-CoV) Betacoronavirus, (β-CoV) 
Gammacoronavirus, (γ-CoV) and Deltacoronavirus. (δ-CoV) [1] α- and β-CoVs are 
able to infect mammals, while γ-and δ-CoVs tend to infect birds [1]. HCoV-229E, 
HCoV-NL63 (α-CoVs) and HCoV-OC43, HCoV-HKU1 (β-CoVs) have crossed the 
species barriers from their bat reservoirs via various intermediate hosts to humans, 
and caused mild endemic infections of the upper respiratory tract such as common 
colds [2]. However, in recent years, several epidemic β-CoVs which were associated 
with severe acute respiratory syndrome (SARS) such as SARS-CoV-1, and middle 
east respiratory syndrome (MERS) such as MERS-CoV were considered as potential 
emergent pathogens for global pandemics [3, 4]. Most recently novel coronavirus 
(NCoV-19) also known as SARS-CoV-2 (β-CoV) which shows 96% genomic 
similarity with bat SARS-like coronavirus strain, BatCov RaTG13 have created the 
currently ongoing pandemic of coronavirus disease 2019. (COVID-19) [5, 6].
SARS-CoV-2 has a round or elliptic shape, often pleomorphic with a diameter of 
approximately 60–140 nm, and a nucleocapsid core surrounded by a lipid bilayer 
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envelope (Figure 1) [7]. The nucleocapsid core contains the viral genome, single-
stranded, non-segmented, positive-sense RNA which has a 5′ cap and a 3′ poly-A 
tail with a length of ~26.4 to ~31.7 kilobase (kb) complexed with the structural 
nucleocapsid (N) proteins (Figure 1) [7]. The lipid bilayer envelope which is taken 
by budding of RNA/nucleocapsid complex into the lumen of the ERGIC (endoplas-
mic reticulum (ER)–Golgi intermediate compartment) has the other structural gly-
coproteins including the spike (S) protein, the membrane (M) protein, the envelope 
(E) protein, and a fifth protein called hemagglutinin-esterase (HE) protein which 
binds to the terminal sialic acid residues on the host cell membrane glycoproteins and 
it manifests acetyl-esterase activity for the egress of SARS CoV-2 (Figure 1) [7, 8].  
S protein, ∼180 kDa glycoprotein is initially cleaved by the host serine protease 
furin resulting non-covalently linked transmembrane S2 subunit and a protruding 
extracellular S1 subunit during the intracellular maturation in the trans-Golgi-
network [9]. Plasma membrane-exposed or secreted furin also cleaves S protein 
during entry of the virus resulting S1/S2 protomers which appear as mushroom-like 
trimers on the viral envelope (Figure 1) [9]. Each of the protomers can have an 
open or closed conformation. The “open” conformation of S1 exposes the receptor 
binding domain, (RBD) containing receptor binding motif (RBM) which shows 
increased binding affinity with angiotensin II-converting enzyme (ACE2) [10]. 
Currently circulating SARS-CoV-2 variant has a S1 D614G mutation with N-linked 
glycosylation sites N165 and N234 which favor the open conformation resulting the 
SARS-CoV-2 D614G variant more infectious [11]. SARS-CoV2 is also unique for 
having a proline residue between S1 and S2 subunits which leads to the formation 
of a turn/stem-loop structure resulting O-linked glycosylation at the cleavage site 
residues S686, S673, and T678 [12]. Following the binding of the amino- (N) termi-
nal of S1 subunit RBM to ACE2, transmembrane protease serine 2 (TMPRSS2) and 
furin-mediated proteolytic activation/cleavage between the carboxyl- (C) terminal 
of S1 and N-terminal of S2 subunits results conformational change and fusion of 
the virus envelope and host cell membrane via C- terminal of S2 subunit, and this 
process delivers the virus genome into the host cell (Figure 2) [8]. SARS-CoV-2 also 
Figure 1. 
Coronavirus structure. (Adapted from Fehr et al. [7]).
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enters the host cell via receptor-mediated endocytosis (Figure 2) [8]. Upon binding 
of N terminal of S1 subunit RBM to ACE2 virion is taken up into the endosome, 
where S1 and S2 subunits are cleaved and activated by the pH-dependent cysteine 
protease, cathepsin L (Figure 2) [8]. Conformational change of the S1and S2 sub-
units allows fusion of the virus envelope with the endosomal membrane and release 
of the viral genome into the cytoplasm (Figure 2) [8]. ADAM17 (a disintegrin and 
metalloprotease 17) also known as tumor necrosis factor-α (TNF- α) converting 
enzyme, (TACE) is a membrane protease involved in the endogenous shedding of 
ACE2 complexed with S1 subunit RBD from the cell membranes (Figure 2) [8]. 
ADAM17-dependent ACE2 shedding is believed to promote lung pathogenesis  
[8, 13]. ACE2, is an essential component of the regulatory mechanism of the renin-
angiotensin-aldosterone system (RAAS), and this pathway is considered to interact 
with the pathophysiology of COVID-19. In this chapter, we will discuss the key role 
of RAAS in the pathogenesis of Covid-19.
2.  The renin: angiotensin: aldosterone system and pathophysiology of 
Covid 19
The RAAS is an important hormonal homeostatic mechanism of the body that 
involves the liver, kidneys, lungs and adrenal glands which plays a critical role in the 
regulation of blood pressure, fluid/electrolyte balance, systemic and pulmonary vas-
cular resistance and vascular remodeling [14]. The function of the RAAS is mainly 
regulated by angiotensinogen, prorenin, renin, angiotensin I, (Ang I) angiotensin II, 
(Ang II) aldosterone, angiotensin 1–7, (Ang 1–7) angiotensin 1–9, (Ang 1–9) angio-
tensin I-converting enzyme, (ACE) and ACE2 (Figure 3) [15]. Prorenin, the precur-
sor of renin, is proteolytically activated in the kidney by neuroendocrine convertase 
1 (proprotein convertase 1) or cathepsin B, and nonproteolytically in many tissues by 
the renin/prorenin receptors [14]. Renin is produced by the juxtaglomerular cells in 
response to sympathetic nervous system (SNS) stimulation, hypotension, decreased 
cardiac output (CO) and renal perfusion pressure, decreased distal tubular sodium 
and chloride concentration and dehydration (Figure 3) [15]. Angiotensinogen, 
synthesized in the liver is an α-2-globulin, a member of the serpin family of proteins, 
but unlike the other serpins it is not known to inhibit proteases (Figure 3) [14, 15]. 
Figure 2. 
Role of host cell proteases in the cellular entry of SARS-CoV. (Adapted from Heurich et al. [8]).
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It has an elongated N-terminus as a substrate for renin which cleaves 10 N-terminus 
amino acids from angiotensinogen and creates the decapeptide Ang I (Figure 3) [15]. 
Ang I is considered to have no direct biological activity other than being a precursor 
to Ang II which is synthesized by ACE through removal of two C-terminal residues 
from Ang I (Figure 3) [15, 16]. ACE belongs to the M2 gluzincin family of metallo-
proteinases, zinc-dependent peptidyldipeptidase and it exists in two forms, somatic 
ACE and testicular ACE [16]. Both are derived from the same gene, controlled by 
alternative promoters [17]. Testicular ACE is considered to play a role in male fertility 
and sperm physiology [18]. Somatic ACE (ACE) is expressed in high amounts by the 
vascular endothelium of the lungs, renal proximal tubular epithelium and ciliated 
intestinal epithelium [17]. ACE mRNA expression has also been identified in dif-
ferent cell types and tissues including macrophages, dendritic cells, (DC) choroidal 
plexus and brain [19, 20]. The ACE gene promoter has been shown to harbor CpG 
islands which regulate ACE gene expression during inflammation via TNF-α, 
dependent hypermethylation resulting a decrease in cellular ACE activity [21, 22]. 
ACE is an integral membrane protein, which can be also cleaved by ACE secretases to 
produce a circulating form of the enzyme [23]. This soluble ACE activity is shown to 
be inhibited by an endogenous inhibitor which restricts ACE mediated Ang I conver-
sion in the systemic circulation irrespective to the concentration of the circulating 
ACE that confines Ang II mediated responses in the tissues [24]. Changes in ACE 
expression have been shown to have minimum effect on blood pressure due to renin-
mediated compensation of Ang I and its bioactive endogenous byproduct angioten-
sin 1–12 (Ang 1–12) which is more specialized for controlling blood pressure than 
Ang II [25, 26]. Ang II is considered to be mostly associated with innate and adaptive 
immunity, oxidative stress, inflammation and fibrosis [27, 28].
The Ang II receptors, (ATR1) and (ATR2), are a class of G protein-coupled 
receptors sharing a sequence identity of ~30%, but having a similar affinity for Ang 
II, which is their main ligand (Figure 3) [15, 16]. ATR2 stimulates the G protein-
coupled receptor Gi subunit, and primarily inhibits the cAMP-dependent pathway 
by inhibiting adenylyl cyclase activity and decreasing the production of cAMP from 
ATP, which in turn results decreased activities of the cAMP-dependent protein 
kinases [29]. The downstream signaling pathways of these inhibitory processes lead 
to the modulation of protein kinase A (PKA), protein kinase C (PKC) and mitogen-
activated protein kinase (MAPK) pathways, eventually inhibiting inflammation and 
Figure 3. 
The renin-angiotensin-aldosterone system (Adapted from Ames et al. [15]).
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growth-specific functional processes mostly affecting cardiac and vascular tissues 
[30]. ATR2 activation was reported to induce the activation of peroxisome prolifera-
tor-activated receptor, (PPARγ) a powerful anti-inflammatory factor in the post-
ischemic cardiac tissue of rabbits that was accompanied by a down-regulation of 
MAPKs p42/44 [31]. ATR1 which stimulates the G protein-coupled receptor Gq 
protein alpha subunit on the vascular smooth muscle cell membranes which in turn 
activates an inositol triphosphate (IP3)-dependent mechanism leading to increase 
intracellular calcium levels and vasoconstriction (Figure 3) [15, 27]. Ang II stimu-
lates aldosterone secretion from the adrenal gland cortex (Figure 3) [15]. 
Aldosterone increases sodium, chloride and bicarbonate reabsorption coupled with 
potassium and hydrogen excretion from the distal convoluted tubules, and amplifies 
the pathophysiologic effects of Ang II in the heart, kidney and vasculature via acting 
on the mineralocorticoid (MR) receptors (Figure 3) [15, 24]. More importantly, 
aldosterone was associated with inflammation via ER unfolded protein responses, 
mitochondrial dysfunction, as well as increased synthesis of pro-inflammatory 
cytokines such as interleukin 6. (IL-6) [32, 33]. It was also disclosed that activation 
of ATR1-receptors promotes Ang II-induced reactive oxygen species (ROS) genera-
tion, inflammation and angiogenesis via stimulating the Nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase, (NOX) nuclear factor kappa-light-chain-
enhancer of activated B cells, (NF-κB) extracellular signal-regulated kinases, 
(ERK1/2) MAPK and signal transducer and activator of transcription 1 (STAT1) 
pathways [34, 35]. NOX is the best known non-mitochondrial source of ROS 
generation [36]. p22phox subunit of NOX is required for activating, stabilizing and/
or regulating NOX homologs [36]. Ang II reportedly induces oxidative stress by 
elevating the expression of p22phox [37]. ROS are considered to oxidize membrane 
phospholipids, proteins and nucleic acids, and lead to tissue hypertrophy and 
inflammation mainly in the alveolar epithelial cells, endothelium and heart via 
triggering the synthesis of adhesion molecules including intercellular adhesion 
molecule 1, (ICAM-1) vascular cell adhesion protein 1, (VCAM-1) monocyte 
chemoattractant protein 1, (MCP-1) and macrophage colony stimulating factor. 
(M-CSF) [34, 35]. Moreover, Ang II stimulates production of ROS from NO leading 
to depletion of NO causing further injury to blood vessels [14]. Additionally, 
C- reactive protein (CRP) induces ATR1 transcription and translation as well as 
enhanced ATR1 levels in blood vessel wall [14, 35]. Heat shock proteins (HSPs) have 
been found to be a regulator of NF-κB cascade in inflammation induced by Ang II 
via activation of the inhibitor of nuclear factor kappa B (IκB) kinase (IKK) complex 
and phosphorylation of IκBα. This process leads to ubiquitination and degradation 
of IκBα, and permits NF-κB translocation to the nucleus. NF-κB stimulates the 
transcription of proinflammatory cytokines including TNF-α, IL-6, IL-8, MCP-1, 
and cyclooxygenase [38]. Cyclooxygenase 1-derived prostaglandin E2 and prosta-
glandin E2 type 1 receptors are considered to play a role in Ang II-dependent 
hypertension via AT1R/phospholipase A2 pathway which promotes ROS production 
coupled with Ca2+ influx [39]. TNF-α, primary substrate for ADAM17 is cleaved and 
released from the cell membrane forming the soluble TNF-α which in turn binds and 
activates TNF-α receptors on the cell surfaces [40]. ADAM17 activity is upregulated 
by the binding of soluble TNF-α to its receptors, and also via the ATR1/Ang II axis 
[40]. Ang II enhances activation of MAPK cascades including ERK1/2, c-Jun 
N-terminal kinase (JNK) and ERK5 via ATR1 resulting increased synthesis of matrix 
metalloproteinase-2 (MMP-2) which amplifies the inflammation associated with the 
proinflammatory cytokines and results to angiogenesis, widespread disruption of 
endothelial barriers and cardiac abnormalities [41]. Activation of STAT1/STAT2 
downstream pathway via Ang II – ATR1 binding stimulates interferon-stimulated 
genes (ISG) expression by inducing the interferon-stimulated response element 
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(ISRE) promoter and increases the maturation and activation of the antigen pre-
senting cells, natural killer cells and T-box expressed in T cells (T-bet) cells which are 
bridging between innate and adaptive immunity and leading to autoimmune 
reactions and cardiovascular diseases [42]. Ang II-induced vasoconstriction and 
inflammatory endothelial cell injury have been associated with accelerated throm-
bus development in the arteries, veins, and capillaries via activation of different 
components of the coagulation cascade [42, 43]. ACE2 is a zinc-carboxypeptidase 
consisting of 805 amino acids with an extracellular N-terminal domain, transmem-
brane (TM) domain and an intracellular C-terminal tail (Figure 4) [44]. The 
zinc-binding motif (HEMGH) is located within the carboxypeptidase domain which 
also recognizes RBM of S1 subunit of SARS-CoV-2 (Figure 4) [44]. Collectrin 
domain is the site for ACE2 shedding with ADAM17 and TMPPSS2, and it is crucial 
for interacting with neutral amino acid transporters (Figure 4) [44]. ACE2, which 
has 42% identical nucleotide sequence with ACE indicating that the two genes, 
ACE2 and ACE arise through duplication [45]. ACE2 is expressed in a diverse group 
of cells including the oral, nasal, type II lung alveolar, tongue and esophageal 
epithelial cells, enterocytes, endothelial cells, cardiomyocytes, arterial smooth 
muscle cells in most organs, cortical neurons and glia, renal tubules, ductal cells, 
bladder urothelial cells and male reproductive cells [44–46]. ACE2 cleaves the 
carboxyl (C)-terminal amino acid phenylalanine from Ang II, (Asp-Arg-Val-Tyr-Ile-
His-Pro-Phe) and hydrolyses it into the vasodilator Ang (1–7), (Asp-Arg-Val-Tyr-Ile-
His-Pro) a ligand for the G-protein coupled receptor Mas receptor (MasR) (Figure 5)  
[47]. ACE2 also converts Ang I to Ang 1–9 that can be further hydrolyzed to Ang 1–7 
by the action of neprilysin, (Nep) which is a zinc-dependent metalloprotease, and 
cleaves peptides at the N-side of hydrophobic residues (Figure 5) [47, 48]. Nep also 
directly converts Ang I to Ang 1–7 which is further enzymatically decarboxylated to 
alamandine, a ligand for Mas-related G-protein-coupled receptor, member D 
(MrgD) (Figure 5) [47, 49]. Activation of Mas and MrgD receptors upon binding 
with Ang 1–7 and alamandine respectively promote anti-inflammatory responses via 
increasing the levels of anti-inflammatory cytokines IL-4 and IL-10 which have been 
disclosed in macrophages and microglial cells [50, 51]. ACE2 is considered as a key 
modulator of the RAAS via regulating physiological and pathological functions of 
cardiovascular, renal and pulmonary systems via counterbalancing the hypertensive, 
vasoconstrictor, hypertrophic and inflammatory effects of ACE [47, 52]. Thus, the 
ratio of Ang II/ACE2 plays an important role in the pathogenesis of several diseases 
including Covid-19 [47, 52, 53]. Two forms of ACE2 have been reported [44].  
Figure 4. 
Domain structure and function of angiotensin-converting enzyme 2. (Adapted from Bian et al. [44]).
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The full-length membrane-bound ACE2 (mACE2) is located on the apical surface of 
epithelial cells, differently from ACE, which is located between the apical and 
basolateral membranes in polarized cells [19, 44]. S1 trimeric subunit RBM of 
SARS-CoV-2 binds to the widely expressed mACE2 extracellular domain (Figures 2 
and 4) [8, 44]. The second form soluble ACE2 (sACE2) is shed into the circulation 
via Ang II/AT1R/ADAM17 axis (Figure 2) [8, 54, 55]. Although the levels of sACE2 
may be increased in plasma or urine in some pathological processes, such as hyper-
tension, the expression levels of mACE2 is not affected [45]. The majority of ACE2 is 
membrane-bound, and it has a compensatory balancing effect on the RAAS [49]. 
Ang II counterbalances the number of mACE2 via cellular internalization through 
endocytosis and degradation in the lysosomes, thus inhibits the antioxidative, 
anti-inflammatory, anti-hypertrophic and antifibrotic effects of ACE2 [55]. ACE2 
inactivity via shedding, cellular internalization and degradation at early stages of 
COVID-19 might have a disturbing effect on the RAAS homeostasis which leads to 
increased vascular permeability, fluid accumulation in the extra-alveolar spaces, 
oxidant/antioxidant imbalance and impaired tissue repair [56, 57]. COVID-19 
patients were found to suffer more frequently from severe endothelial injury due to 
the membrane damage by binding of SARS-CoV-2 [58]. Widespread thrombosis 
with microangiopathies were reported, and the COVID-19 patients were found 9 
times more likely to experience alveolar capillary microthrombi, and 2.7 times more 
likely to experience intussusceptive angiogenesis than the patients with flu [59]. This 
phenomenon of thrombosis and other vascular events in COVID-19 were considered 
more likely associated with abundance of ACE2 on the endothelial cell membranes 
which permit SARS-CoV-2 infection along the endothelium resulting endothelial 
damage, complement activation, release of Von-Willebrand factor from the endo-
thelial cells, hypercoagulability and microthrombi formation [58, 59]. ACE2 expres-
sion is regulated by genetic and epigenetic factors, body mass index, inflammatory 
cytokines, cigarette smoking, sex hormones and aging. ACE2 expression in different 
Figure 5. 
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tissues across human individuals were found to be high in Asian ethnic groups [60]. 
The upregulation of ACE2 expression was associated with the decline in the levels of 
estrogen and androgen, aging, inflammation and cigarette smoking [60, 61].
Cis-elements in the proximal promoters of ACE2 genes have binding sites for 
canonical interferon- (IFN) dependent transcription factors including ISRE/
STAT1, interferon regulatory factor 1 (IRF1), IRF3/7 and IRF8 [62]. Type I IFNs, 
and to a lesser extent type II and type III IFNs have been shown to upregulate ACE2 
expression especially in the human upper airway basal cells and bronchial cells [63]. 
Higher enrichment of ISRE/STAT1/3 and/or IRF3/7 binding sites were detected 
in single cell RNA-sequence data sets from the nasal epithelium and upper airway 
goblet secretory cells of the patients with the severe manifestations of COVID-19 
suggesting dual roles of ACE2 in the pathogenesis of SARS- COV-2 [64]. First, 
ACE2 serves as an innate immune receptor for SARS-CoV-2 which might compete 
with Ang II for the binding sites located at the carboxypeptidase domain of ACE2, 
and SARS-COV-2 gains access into the cells via ACE2 receptor. The similar func-
tional innate protein–protein interactions between the human toll-like receptors 
(TLRs) TLR1, TLR4, and TLR6 with a binding energy values of −57.3, −120.2, −68.4 
respectively, being the TLR4-S protein interaction strongest have been demon-
strated by the molecular docking [65]. Secondly, innate IFN responses against 
SARS-CoV-2 upregulate ACE2 expression on the cell membranes which augments 
anti-inflammatory responses via counter-balancing the effects of Ang II, but also 
allows further cellular entry of SARS-CoV-2. However; the balancing arm of the 
RAAS functioning as ADAM17 mediated ACE2 shedding and ADAM17 mediated 
TNF-α activation/hypermethylation of the CpG islands at the ACE gene promoter 
eventually decrease cellular entry of SARS-CoV-2 and ACE expression.
In summary, there are couple of balancing and counter-balancing factors exist-
ing in the pathogenesis of Covid-19. The main counter-balancing arm is between 
Renin/ACE/Ang II/ATR1 and ATR2/ACE2/Mas/MrgD. The second counter-balanc-
ing arm is between the innate immune responses including SARS- CoV-2 induced 
IFN response/increased membrane expression of ACE2, and ADAM17 mediated 
ACE2 shedding activated by ATR1/Ang II and TNF-α mediated downregulation 
of ACE expression. The second arm has its own feedback via TNF-α. However, the 
main arm counter-balancing the protective and deleterious effects of RAAS which 
is being abused by SARS- CoV-2 via competing with Ang II for binding to the ACE2 
receptor plays a crucial role in the pathogenesis of Covid-19 via the unopposed 
effects of Ang II including oxidative stress, inflammation, stimulation of innate and 
adaptive immunity via T-bet cells, thrombosis, angiogenesis and fibrosis.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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